TNBI OTC
Tanke Biosciences Corporation
1W: +0.0%
1M: -50.0%
3M: -50.0%
YTD: -66.7%
1Y: -80.0%
3Y: -87.5%
5Y: -99.2%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$35K
+53.3% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$35K
+53.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3K
+43.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$229K | -$723K | -$98K | -$83K | -$120K |
| Depreciation & Amort. | $636K | $0 | $0 | $8K | $978 |
| Stock-Based Comp. | $0 | $663K | $70 | $0 | $0 |
| Change in Working Capital | -$5M | $2K | $3K | $20K | $84K |
| Other Non-Cash Items | $4M | $55K | $36K | -$20K | $0 |
| Operating Cash Flow | -$1M | -$4K | -$59K | -$75K | -$35K |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $190K | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$861K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2M | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $647K | $0 | $25K | $70K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $475K | $45K | $0 | $0 | $28K |
| Financing Cash Flow | $1M | $45K | $25K | $70K | $32K |
| Net Change in Cash | -$2M | $41K | -$34K | -$5K | -$3K |
| Cash End of Period | $6M | $41K | $7K | $3K | $0 |
| Free Cash Flow | -$3M | -$4K | -$59K | -$75K | -$35K |